13. 多発性硬化症／視神経脊髄炎 Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details

臨床試験数 : 3,340 / 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238

33 trials found

diseases per page:

Showing 1 to 10 of 33 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2008-004954-34-AT (EUCTR)	21/01/2010	09/12/2008	Long-term Follow-Up of Patients Who Participated in Study 27025 (REFLEX)	Double-blind extension of the study 27025 (REFLEX) to obtain long-term follow-up data in patients wi ...	Subjects of high risk of converting to Multiple Sclerosis or subjects already converted to Multiple ...	Trade Name: Rebif INN or Proposed INN: Interferon-beta 1a	Merck Serono S.A. - Geneva, an affiliate of Merck KGaA, Darmstadt, Germany	NULL	Not Recruiting			Female: yes Male: yes	492		Portugal;Serbia;Estonia;Morocco;Slovakia;Greece;Spain;Lebanon;Israel;Russian Federation;Italy;France ...
2	NCT01101776 (ClinicalTrials.gov)	January 2010	8/4/2010	Post Marketing Surveillance Study to Evaluate the Tolerability of Rebif® New Formulationin Patients ...	Post Marketing Surveillance Study to Evaluate the Tolerability of Rebif® New Formulationin Patients ...	Multiple Sclerosis	Drug: Interferon beta -1a (Rebif)	Merck KGaA	Merck Serono Australia Pty Ltd	Completed	18 Years	N/A	Both	49	N/A	Australia
3	EUCTR2008-004954-34-PL (EUCTR)	09/09/2009	05/06/2009	Long-term Follow-Up of Patients Who Participated in Study 27025 (REFLEX)	Double-blind extension of the study 27025 (REFLEX) to obtain long-term follow-up data in patients wi ...	Subjects of high risk of converting to Multiple Sclerosis or subjects already converted to Multiple ...	Trade Name: Rebif INN or Proposed INN: Interferon-beta 1a	Merck Serono S.A. - Geneva, an affiliate of Merck KGaA, Darmstadt, Germany	NULL	Not Recruiting			Female: yes Male: yes	492		Serbia;Portugal;Estonia;Slovakia;Morocco;Greece;Spain;Lebanon;Russian Federation;Israel;Italy;France ...
4	EUCTR2008-004954-34-BG (EUCTR)	28/05/2009	29/05/2009	Long-term Follow-Up of Patients Who Participated in Study 27025 (REFLEX)	Double-blind extension of the study 27025 (REFLEX) to obtain long-term follow-up data in patients wi ...	Subjects of high risk of converting to Multiple Sclerosis or subjects already converted to Multiple ...	Trade Name: Rebif INN or Proposed INN: Interferon-beta 1a	Merck Serono S.A. - Geneva, an affiliate of Merck KGaA, Darmstadt, Germany	NULL	Not Recruiting			Female: yes Male: yes	492		Portugal;Serbia;Estonia;Morocco;Slovakia;Greece;Spain;Lebanon;Israel;Russian Federation;Italy;France ...
5	EUCTR2008-004954-34-GR (EUCTR)	19/05/2009	06/03/2009	Double-blind extension of the study 27025 (REFLEX) to obtain long-term follow-up data in patients wi ...	Double-blind extension of the study 27025 (REFLEX) to obtain long-term follow-up data in patients wi ...	Subjects of high risk of converting to Multiple Sclerosis or subjects already converted to Multiple ...	Trade Name: Rebif INN or Proposed INN: Interferon-beta 1a	Merck Serono International, a branch of Laboratoires Serono SA an affiliate of Merck KGaA, Darmstadt ...	NULL	Not Recruiting			Female: yes Male: yes	492		Portugal;Estonia;Greece;Finland;Spain;Austria;Italy;France;Czech Republic;Poland;Belgium;Bulgaria;Ge ...
6	EUCTR2008-004954-34-DE (EUCTR)	05/05/2009	15/01/2009	Long-term Follow-Up of Patients Who Participated in Study 27025 (REFLEX)	Double-blind extension of the study 27025 (REFLEX) to obtain long-term follow-up data in patients wi ...	Subjects of high risk of converting to Multiple Sclerosis or subjects already converted to Multiple ...	Trade Name: Rebif INN or Proposed INN: Interferon-beta 1a	Merck Serono S.A. - Geneva, an affiliate of Merck KGaA, Darmstadt, Germany	NULL	Not Recruiting			Female: yes Male: yes	492		Serbia;Portugal;Estonia;Slovakia;Morocco;Greece;Spain;Lebanon;Russian Federation;Israel;Italy;France ...
7	EUCTR2008-004954-34-FR (EUCTR)	08/04/2009	17/03/2009	Double-blind extension of the study 27025 (REFLEX) to obtain long-term follow-up data in patients wi ...	Double-blind extension of the study 27025 (REFLEX) to obtain long-term follow-up data in patients wi ...	Subjects of high risk of converting to Multiple Sclerosis or subjects already converted to Multiple ...	Trade Name: Rebif INN or Proposed INN: Interferon-beta 1a	Merck Serono S.A.- Geneva, an affiliate of Merck KGaA, Darmstadt, Germany	NULL	Not Recruiting			Female: yes Male: yes	492	Phase 3	Portugal;Estonia;Slovakia;Greece;Finland;Spain;Austria;Italy;France;Czech Republic;Poland;Belgium;Bu ...
8	EUCTR2008-004954-34-LV (EUCTR)	12/03/2009	27/02/2009	Double-blind extension of the study 27025 (REFLEX) to obtain long-term follow-up data in patients wi ...	Double-blind extension of the study 27025 (REFLEX) to obtain long-term follow-up data in patients wi ...	Subjects of high risk of converting to Multiple Sclerosis or subjects already converted to Multiple ...	Trade Name: Rebif INN or Proposed INN: Interferon-beta 1a	Merck Serono S.A. - Geneva, an affiliate of Merck KGaA, Darmstadt, Germany	NULL	Not Recruiting			Female: yes Male: yes	492		Portugal;Estonia;Greece;Finland;Spain;Austria;Italy;France;Czech Republic;Poland;Belgium;Bulgaria;La ...
9	EUCTR2008-004954-34-BE (EUCTR)	09/03/2009	23/01/2009	Long-term Follow-Up of Patients Who Participated in Study 27025 (REFLEX)	Double-blind extension of the study 27025 (REFLEX) to obtain long-term follow-up data in patients wi ...	Subjects of high risk of converting to Multiple Sclerosis or subjects already converted to Multiple ...	Trade Name: Rebif INN or Proposed INN: Interferon-beta 1a	Merck Serono S.A. - Geneva, an affiliate of Merck KGaA, Darmstadt, Germany	NULL	Not Recruiting			Female: yes Male: yes	492	Phase 3	Serbia;Portugal;Estonia;Slovakia;Morocco;Greece;Spain;Lebanon;Russian Federation;Israel;Italy;France ...
10	EUCTR2008-004954-34-SK (EUCTR)	05/03/2009	09/09/2009	Long-term Follow-Up of Patients Who Participated in Study 27025 (REFLEX)	Double-blind extension of the study 27025 (REFLEX) to obtain long-term follow-up data in patients wi ...	Subjects of high risk of converting to Multiple Sclerosis or subjects already converted to Multiple ...	Trade Name: Rebif INN or Proposed INN: Interferon-beta 1a	Merck Serono S.A. - Geneva, an affiliate of Merck KGaA, Darmstadt, Germany	NULL	Not Recruiting			Female: yes Male: yes	492	Phase 3	Serbia;Portugal;Estonia;Slovakia;Morocco;Greece;Spain;Lebanon;Russian Federation;Israel;Italy;France ...

First Previous1 2 3 4Next Last